Search

Your search keyword '"Bregni, Marco"' showing total 425 results

Search Constraints

Start Over You searched for: Author "Bregni, Marco" Remove constraint Author: "Bregni, Marco"
425 results on '"Bregni, Marco"'

Search Results

3. On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective Study

7. Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

8. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

12. Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012

13. Supplementary Data 3 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

14. Supplementary Data 1 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

15. Data from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

16. uncropped western blot gels from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

17. Supplementary Data 4 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

18. Supplementary Data 2 from Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

19. High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry

20. Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry

23. Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy

24. Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib

26. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

28. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

29. Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

30. Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib

31. Gene therapy for immunodeficiency due to adenosine deaminase deficiency

33. Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity

35. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina

37. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia

40. Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma

41. Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes

44. Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.

45. Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non‐Hodgkin B‐cell lymphomas

Catalog

Books, media, physical & digital resources